Altered concentrations of appetite regulators may contribute to the development and maintenance of HIV-associated wasting

AIDS

Volumn 11, Issue 9, 1997, Pages 1129-1134

  Arnalich, Francisco ^a,b   Martinez, Pedro ^a   Hernanz, Angel ^a   González, Juan ^a   Plaza, María A ^a   Montiel, Carmen ^a   Peña, José M ^a   Vázquez, Juan J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

endorphin; AIDS; Anorexia; Cholecystokinin; HIV wasting; Malnutrition; Nutritional status; Soluble tumour necrosis factor (TNF) receptors; TNF

Indexed keywords

BETA ENDORPHIN; CHOLECYSTOKININ OCTAPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FOOD INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SPAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; APPETITE; BETA-ENDORPHIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV WASTING SYNDROME; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RECEPTORS, TUMOR NECROSIS FACTOR; SINCALIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030996988     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199709000-00008     Document Type: Article

References (32)

1. Grunfield C, Feingold KR: Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:329-337.
2. Macallan DC, Noble C, Balwin C, Foskett M, McManus P, Griffin GE: Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993, 58:417-424.
3. Grunfield C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR: Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992, 55:455-460.
4. Kotler DP, Tierny AR, Wang J et al.: Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989, 50:444-447.
5. Stein IP, Nutinsky C, Condoluci D, Schluter MD, Leskiw MJ: Protein and energy substrate metabolism in AIDS patients. Metabolism 1990, 39:876-881.
6. Lahdevirta J, Maury CPJ, Teppo AM, Repo H: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988, 85:289-291.
7. Matsuyama I, Kobayashi N, Yamamoto N: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991, 5:1405-1417.
8. Tracey KJ: Tumour necrosis factor-alpha. In The Cytokine Handbook, 2nd edn. London: Academic Press Limited; 1994: 289-304.
9. Godfried MH, van der Poll T, Jansen J, et al.: Soluble receptors for for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 1993, 7:33-36.
10. Aukrust P, Liebakk NB, Müller F, Lien L, Espevik T, Froland SS: Serum levels of Tumor necrosis factor-alpha (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection Correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994, 169:420-424.
11. Godfried MH, van der Poll L, Weverling GJ, et al.: Soluble receptors for tumour necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type-1 infection. J Infect Dis 1994, 169:739-745.
12. Zangerle R, Gallati H, Sarcletti M, et al.: Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 1994, 7:79-85
13. Martinez M, Hernanz A, Gómez-Cerezo J, Peña JM, Vázquez JI, Arnalich F: Alterations in plasma and cerebrospinal fluid levels of neuropeptides in idiopathic senile anorexia. Regul Pept 1993, 49:109-117.
14. Martinez M, Arnalich F, Hernanz A: Alterations of anorectic cytokine levels from plasma and cerebrospinal fluid in idiopathic senile anorexia. Mech Ageing Develop 1993, 72:145-153.
15. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR CDC Surveill Summ 1987, 36 (suppl 1):3S-14S.
16. Frisancho AR: New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981, 34:2540-2545.
17. Durnin JVGA, Womersley I: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974, 32:77-97.
18. Struwe M, Kaemfer SH, Gerger CJ, et al.: Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993, 27:827-831.
19. Macallan DC, Noble C, Baldwin C, et al.: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995, 333:83-88.
20. Turnbull AV, Rivier CR: Cytokines within the neuroendocrine system. Curr Opinion Endocr Diab 1996, 3:149-156.
21. Ballinger A, McLoughlin L, Medbak S, Clark M: Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations. Clin Sci 1995, 89:375-381.
22. Levine AS, Billington CJ: Opiods : are they regulators of feeding? Physiol Biochem Behavr 1989, 575:209-219.
23. Morley JL: Neuropeptide regulation of appetite and weight. Endocr Rev 1987, 8:256-287.
24. Islam AK, Bodnar RJ: Selective opiod receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res 1990, 508:293-296.
25. Horvath TL, Naftolin F, Kalra SP, Leranth C: Neuropeptide Y innervation of ß-endorphin-containing cells in the rat mediobasal hypothalamus: a light- and electronmicroscopic double-immunostaining analysis. Endocrinology 1992, 131:2461-2467.
26. Süttmann U, Selberg O, Gallati H, Ockenga J, Deicher H, Müller MJ: Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients. Clin Sci 1994, 86:461-467.
27. Godfried MH, Romijn JA, van der Poll, et al.: Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism 1995, 44:1564-1569.
28. Van Zee KJ, Kohno T, Fischer F, Rock CS, Moldawer LU, Lowry SF: TNF-soluble receptors circulate during experimental and clinical inflammation and can protect against excessive TNF-alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992, 89:4845-4849.
29. Thea DM, Porat R, Nagimbi K, et al.: Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 1996, 124:757-762.
30. Lorun B, Viteri FF. Protein-energy malnutrition. In Modern nutrition in health and disease. Edited by Shils ME, Young VR. Philadelphia: Lea & Febiger: 1988:746-773.
31. Fohlin L: Body composition, cardiovascular and renal function in adolescent patients with anorexia nervosa. Acta Paediatr Scand 1977, 268 (suppl 2):7-20.
32. Dempsey DT, Croshy LO, Lusk E, Oberlander JL, Pertschuh MJ, Mullen JL: Total body water and total body potassium in anorexia nervosa. Am J Clin Nutr 1984, 40:260-269.